Australian Pharmaceutical Manufacturers Association

1
Australian Pharmaceutical Manufacturers
Association

2002 and beyond

• Alan H Evans
• Chief Executive Officer

2
APMA Two Years on

• Participative development of a
• strategy by members
• Strategy endorsed by members
• Strategy in operation for 18
• Months

3
APMA Two Years on
The strategy has three main elements 1.
Analysing and promoting the economic impact
and benefits of the industry 2. Enhancing the
industrys image 3. Creating a favourable
investment climate
4
APMA Two Years on

• To analyse and promote the economic impact and
  benefits of the industry
• We recruited specialist staff with broad policy
  as well as specific economic skills
• built a micro-simulation econometric model of the
  PBS to better understand effects of various
  policies on the PBS over the next five to ten
  years

5
APMA Two Years on

• To enhance the industrys image
• restructured the APMA Secretariat
• Appointed a Director of Strategic Relations
• Developed and implemented an Industry
• Communications Plan
• Appointed a Health Consumers Relations Manager
• Constantly developing key messages for
• industry

6
APMA Two Years on

• Relocated the National Office to Canberra,
• Tackling negatives issues before they arise,
• Being prepared to forcefully argue our case
  publicly if and when issues arise
• Changing the language
• Renaming the organisation

7
APMA Two Years on

8
APMA Two Years on

• Developed the APMA CommunityCare Program which
• focuses on activities both core and non core,
• develops industry champions from outside the
  industry
• supports bodies which champion the benefits of
  the industry in Australia

9
APMA Two Years on

• To create a favourable investment climate
• Identified the drivers of and the constraints to
  investment in the pharmaceutical industry in
  Australia and comparable countries
• Developed options on the measures necessary to
  create an attractive investment environment in
  Australia to put to government

10
APMA Two Years on

• Had the Government establish an Action Agenda to
  develop a whole of Government and Industry
  Strategy for the growth of the industry in
  Australia
• Continually seeking bipartisan and multi-interest
  agreement to the steps necessary to ensure
  Australia has a viable pharmaceutical industry

11
APMA the next two Years

• Goals for the Industry
• Appreciated by consumers and health care
  professionals for the benefits for the quality of
  life of our products.
• Recognised as a major contributor to national
  economic well being through improved health
  outcomes.
• Recognised by the community as a vital and
  essential part of Australian society and a
  significant contributor to the economy.

12
The Challenges Ahead

• Failure of Policy
• Industry Unity
• Changing the perception of our industry
• Empowering consumers

13
The Challenges Ahead

• Failure of Policy
• Health Ministry forfeited control of the agenda
  to Treasury and Finance-2002 Budget
• Cost becoming the dominant determiner of listing
• lack of understanding of industry dynamics

14
The Challenges Ahead

• Industry Unity
• Dog eat Dog prevails as pressure to deliver
  bottom line increases
• Cost containment measures such as price/volume
  drive wedges into industry
• Increased transparency of processes creates
  tensions

15
The Challenges Ahead

• Perception of Industry
• Consumers attitude that profit and health dont
  go together
• Idealogues will become more vocal and strident
• Sitting duck for tabloid journalism

16
The Challenges Ahead

• Empowering Consumers
• Everybody wants to control the system
• Want to keep us and the consumers out of the
  equation
• Patient organisations poorly resourced
• Consumer bureaucrats

17
A.P.M.A. Actions

• Failure of Policy
• Inform Public of the benefits of the industry and
  what life would be like without us
• Develop PBS Model to demonstrate Health Outcomes
• Inform all MPs of value of Industry and its
  products

18
A.P.M.A. Actions

• Failure of Policy
• Generate support for a White Paper on the
  provision of pharmaceuticals in Australia
• Co-ordinated approach by industry to educate
  bureacrats on the value of industry
• Get Government to implement the Action Agenda

19
A.P.M.A. Actions

• Industry Unity
• Identify issues with the potential to divide
• Debate and discuss key issues-look 5-10 years out
  and agree on policies
• Remember what goes around comes around

20
A.P.M.A. Actions

• Perception of Industry
• Review all of our practices-will they pass the
  Sunday test
• Agree to be more open and transparent
• Become more engaged with the community

21
A.P.M.A. Actions

• Empowering Consumers
• Build stronger relations with patient groups
• Provide more support for patient groups
• Establish comprehensive information site for
  consumers

22
The Future

• Window of Opportunity
• for
• Australia to be the hub for pharmaceuticals and
  pharmaceutical services in the region